In addition, FCGR3A expression was associated with CD8+ T cell levels in 25 cancer types, CD4+T cell levels in 28 cancer types, macrophage levels in 27 cancer types, neutrophil levels in 30 cancer types, and dendritic cell (DC) levels in 30 cancer types (Table S2). Here, FCGR3A is linked to cancer.